Hinova Anelia, Fernando Roshan
Department of Anesthesia, St. Mary's Hospital, UK.
Anesth Analg. 2009 Dec;109(6):1925-9. doi: 10.1213/ANE.0b013e3181c03e0c.
There is a need for safe, effective, and easy-to-administer systemic analgesia that ideally has rapid onset and offset, matches the time course of uterine contractions, and does not compromise the fetus. Although neuraxial blockade is the "gold standard" for labor analgesia, systemic analgesia is useful in those cases in which neuraxial analgesia is contraindicated, refused or simply not needed by the parturient, or when skilled anesthesia providers are not available. Because of its unique pharmacologic properties, remifentanil has been investigated, and is used clinically, to provide IV labor analgesia. In this focused review, we summarize the efficacy of remifentanil as a labor analgesic and review the current literature regarding its dose, mode of delivery, safety for the mother and fetus/neonate, as well as the scope for future research.
需要一种安全、有效且易于给药的全身镇痛方法,理想情况下其起效和消退迅速,与子宫收缩的时间进程相匹配,且不影响胎儿。尽管神经轴阻滞是分娩镇痛的“金标准”,但全身镇痛在神经轴镇痛禁忌、产妇拒绝或根本不需要,或没有熟练的麻醉人员时仍很有用。由于其独特的药理特性,瑞芬太尼已被研究并用于临床以提供静脉分娩镇痛。在这篇重点综述中,我们总结了瑞芬太尼作为分娩镇痛药的疗效,并回顾了关于其剂量、给药方式、对母婴/新生儿的安全性以及未来研究范围的现有文献。